C4 Therapeutics Ownership | Who Owns C4 Therapeutics?
C4 Therapeutics Ownership Summary
C4 Therapeutics is owned by 30.31% institutional investors, 9.79% insiders, and 59.90% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 10.23% of CCCC shares. Wasatch Ultra Growth is the top mutual fund, with 7.25% of its assets in C4 Therapeutics shares.
CCCC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | C4 Therapeutics | 30.31% | 9.79% | 59.90% |
Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Lynx1 capital management lp | 7.10M | 10.23% | $11.36M |
Soleus capital management | 6.98M | 10.06% | $11.17M |
Orbimed advisors | 6.83M | 9.85% | $10.93M |
Wasatch advisors lp | 6.07M | 8.72% | $21.86M |
Blackrock funding, inc. /de | 5.56M | 7.98% | $20.01M |
Blackrock | 4.55M | 6.61% | $21.03M |
Vanguard group | 3.35M | 4.81% | $12.05M |
Bank of america corp /de/ | 1.77M | 2.57% | $8.17M |
Adage capital partners gp | 1.55M | 2.23% | $5.58M |
Geode capital management | 1.38M | 1.98% | $4.97M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Lynx1 capital management lp | 7.10M | 4.07% | $11.36M |
Soleus capital management | 6.98M | 0.80% | $11.17M |
Bain capital life sciences investors | 1.11M | 0.47% | $4.00M |
Orbimed advisors | 6.83M | 0.26% | $10.93M |
Tang capital management | 900.00K | 0.21% | $3.24M |
Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group | 85.00K | 0.18% | $306.00K |
Wasatch advisors lp | 6.07M | 0.11% | $21.86M |
Intrepid family office | 40.00K | 0.09% | $64.00K |
Arrowmark colorado | 1.33M | 0.06% | $4.80M |
Atom investors lp | 101.68K | 0.05% | $366.06K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 4.55M | 0.00% | 3.65M |
Orbimed advisors | 6.83M | 0.26% | 2.45M |
Adage capital partners gp | 1.55M | 0.01% | 1.03M |
Blackrock funding, inc. /de | 5.56M | 0.00% | 667.92K |
Morgan stanley | 1.14M | 0.00% | 623.75K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ra capital management | - | - | -4.88M |
Commodore capital lp | - | - | -3.41M |
Samlyn capital | - | - | -3.02M |
State street | 1.22M | 0.00% | -1.58M |
Tcg crossover management | - | - | -1.28M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Susquehanna fundamental investments | 108.66K | 0.01% | 108.66K | $391.19K |
Lpl financial | 22.10K | 0.00% | 22.10K | $102.10K |
China universal asset management | 14.97K | 0.01% | 14.97K | $53.88K |
B. riley wealth advisors | 11.00K | 0.00% | 11.00K | $50.82K |
Bnp paribas arbitrage, snc | 6.74K | - | 6.74K | $24.27K |
Sold Out
Holder | Change |
---|---|
Gradient investments | -25.00 |
Coldstream capital management | -52.00 |
Capital performance advisors llp | -54.00 |
Rothschild investment | -70.00 |
Cape investment advisory | -100.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 6 | -95.20% | 21,025,800 | -67.35% | 30 | 0.35% | 4 | -93.85% | 1 | -96.97% |
Dec 31, 2024 | 122 | -5.43% | 64,367,933 | 0.29% | 92 | 1.09% | 63 | -7.35% | 33 | 3.13% |
Sep 30, 2024 | 126 | 5.88% | 64,029,825 | 5.20% | 91 | 1.18% | 67 | 1.52% | 33 | -2.94% |
Jun 30, 2024 | 119 | 7.21% | 60,865,031 | 4.84% | 88 | 1.23% | 66 | -1.49% | 34 | 25.93% |
Mar 31, 2024 | 111 | 16.84% | 58,053,690 | 23.80% | 84 | 1.01% | 67 | 21.82% | 27 | 8.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Wasatch Ultra Growth | 5.15M | 7.25% | 593.72K |
Vanguard US Total Market Shares ETF | 2.14M | 3.01% | - |
Vanguard Total Stock Mkt Idx Inv | 2.07M | 2.92% | - |
Biotech Growth Ord | 1.75M | 2.47% | - |
SPDR® S&P Biotech ETF | 1.57M | 2.22% | 22.34K |
iShares Russell 2000 ETF | 1.53M | 2.16% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 840.16K | 1.18% | - |
Wasatch Micro Cap | 758.27K | 1.07% | -483.88K |
Fidelity Small Cap Index | 623.59K | 0.88% | -8.75K |
iShares Russell 2000 Value ETF | 560.98K | 0.79% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 18, 2025 | Boyle Scott N | Chief Business Officer | Sell | $2.11K |
Feb 14, 2025 | Boyle Scott N | Chief Business Officer | Sell | $1.54K |
Feb 08, 2023 | Koppikar Utpal | - | Buy | $31.74K |
Apr 12, 2022 | Hirsch Andrew | President & CEO | Buy | $84.00K |
Jan 04, 2022 | Crystal Adam | Chief Medical Officer | Sell | $440.55K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | - | 2 |
2024 Q4 | - | - |
2024 Q3 | - | - |
CCCC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools